The vote, which was originally scheduled for March 12, will now be held May 12. The companies said they expect to be able to comply with the FTC’s request in April and to receive an update on its review in May.
Mentor, Ohio-based Steris and U.K.-based Synergy had hoped to complete the merger in June. Because of the delay, the long-stop date has been extended to July 12, pending U.K. court approval. Steris’ bridge credit agreement has likewise been extended to July 12.
U.K. anti-trust regulators green-lighted the proposed $2 billion inversion merger in February.
Under the proposed merger, announced last October, Steris will reincorporate as a British company, a move that should lower its effective tax rate from around 31.3% to 25%.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.